#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4612761	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 0.2 to 1 uM preincubated for 6 hrs followed by biotinylated-THZ1 addition and measured Western blotting based pulldown assay	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
2.	ALA4612765	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down by measuring residual protein level at 500 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition and measured Western blotting based pulldown assay relative to control	Homo sapiens	23	ALA4610118	cell-based format	Scientific Literature
3.	ALA4612780	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 40 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition and measured Western blotting based pulldown assay	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
4.	ALA4612781	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human HAP1 cells assessed as reduction in cyclin K pull down at 40 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition and measured Western blotting based pulldown assay	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
5.	ALA4612785	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues at 40 to 200 nM measured after 6 hrs by Western blot analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
6.	ALA4612786	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser5 residues at 40 to 200 nM measured after 6 hrs by Western blot analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
7.	ALA4612787	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser7 residues at 40 to 200 nM measured after 6 hrs by Western blot analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
8.	ALA4612788	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RNA Polymerase 2 expression at 40 to 200 nM measured after 6 hrs by Western blot analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
9.	ALA4612801	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RAD51 expression at 40 to 200 nM measured after 24 hrs by Western blot analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
10.	ALA4612802	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RAD51C expression at 40 to 200 nM measured after 24 hrs by Western blot analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
11.	ALA4612803	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RAD51 RNA expression at 40 to 200 nM measured after 24 hrs by RT-qPCR analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
12.	ALA4612804	B	Inhibition of CDK12/CDK13 in human HAP1 cells assessed as reduction in RAD51C RNA expression at 40 to 200 nM measured after 24 hrs by RT-qPCR analysis	Homo sapiens	1	ALA4610118	cell-based format	Scientific Literature
13.	ALA4739788	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 62.5 to 1000 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition by Western blotting based pulldown assay	Homo sapiens	1	ALA4739712	cell-based format	Patent Bioactivity Data
14.	ALA4739790	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 25 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition by Western blotting based pulldown assay	Homo sapiens	3	ALA4739712	cell-based format	Patent Bioactivity Data
15.	ALA4739791	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 500 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition by Western blotting based pulldown assay	Homo sapiens	13	ALA4739712	cell-based format	Patent Bioactivity Data
16.	ALA4739794	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 500 nM preincubated for 4 hrs followed by biotinylated-THZ1 addition by Western blotting based pulldown assay	Homo sapiens	4	ALA4739712	cell-based format	Patent Bioactivity Data
17.	ALA4739796	B	Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 1 uM preincubated for 6 hrs followed by biotinylated-THZ1 addition by Western blotting based pull-down assay	Homo sapiens	2	ALA4739714	cell-based format	Patent Bioactivity Data
18.	ALA4828805	B	Inhibition of CDK12/13 in human jurkat cells assessed as reduction in RNA polymerase 2 CTD phosphorylation at Ser2 residue at 0.5 uM measured after 6 hrs by immunoblotting analysis	Homo sapiens	1	ALA4828703	cell-based format	Scientific Literature
19.	ALA4828806	B	Inhibition of CDK12/13 in human jurkat cells assessed as reduction in RNA polymerase 2 CTD phosphorylation at Ser2 residue at 1 uM measured after 6 hrs by immunoblotting analysis	Homo sapiens	2	ALA4828703	cell-based format	Scientific Literature
20.	ALA4828807	B	Inhibition of CDK12/13 in human Jurkat cells assessed as BRCA1 gene expression at 0.5 to 1 uM incubated for 4 hrs by RT-qPCR analysis	Homo sapiens	1	ALA4828703	cell-based format	Scientific Literature